アフターアワーズ： 22.38

Enliven Therapeutics Inc (ELVN)

Enliven Therapeutics Inc (ELVN) 最新ニュース

Enliven Therapeutics Inc (ELVN)

Enliven Therapeutics Inc (ELVN) 最新ニュース

First Turn Management LLC Purchases New Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat

Enliven Therapeutics, Inc. Forecasted to Post Q3 2024 Earnings of ($0.46) Per Share (NASDAQ:ELVN) - Defense World

Enliven Therapeutics Inc [ELVN] Insider Activity: An Update for Investors - Knox Daily

HC Wainwright Comments on Enliven Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:ELVN) - MarketBeat

Research Analysts Offer Predictions for Enliven Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:ELVN) - Defense World

Enliven Therapeutics, Inc. (NASDAQ:ELVN) to Post Q1 2025 Earnings of ($0.52) Per Share, HC Wainwright Forecasts - MarketBeat

Enliven Therapeutics (NASDAQ:ELVN) Now Covered by Analysts at HC Wainwright - Defense World

HC Wainwright Initiates Coverage on Enliven Therapeutics (NASDAQ:ELVN) - MarketBeat

Enliven Therapeutics (NASDAQ:ELVN) Trading Up 8.9% - MarketBeat

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst - Yahoo Finance

Enliven Therapeutics stock starts at Buy with H.C. Wainwright; sees potential in next-gen cancer treatments - Investing.com Canada

Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High? - MSN

Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High? - Yahoo Finance

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Joseph P. Lyssikatos Sells 12,000 Shares of Stock - Defense World

Enliven Therapeutics executive sells over $269k in stock - Investing.com

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Sells $269,880.00 in Stock - MarketBeat

Enliven Therapeutics executive sells over $269k in stock By Investing.com - Investing.com Canada

Enliven Therapeutics (NASDAQ:ELVN) Shares Up 4.8% - MarketBeat

How the (ELVN) price action is used to our Advantage - Stock Traders Daily

Enliven Therapeutics CFO sells over $95k in company stock - Investing.com India

Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Sells 4,250 Shares of Stock - MarketBeat

Enliven Therapeutics CEO sells $274k in company stock By Investing.com - Investing.com Australia

Enliven Therapeutics CFO sells over $95k in company stock - Investing.com

Enliven Therapeutics CEO sells $274k in company stock - Investing.com India

Enliven Therapeutics CEO sells $274k in company stock - Investing.com

Enliven Therapeutics (NASDAQ:ELVN) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

An Analysis of Enliven Therapeutics Inc (ELVN)’s Potential Price Growth - Knox Daily

New Raf kinase inhibitors disclosed in Enliven Therapeutics patent - BioWorld Online

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024 - MSN

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Richard A. Heyman Sells 1,270 Shares - Defense World

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Richard A. Heyman Sells 1,270 Shares - MarketBeat

Enliven Therapeutics director sells over $29k in company stock - Investing.com

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 4% - MarketBeat

Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet - MSN

Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet - Yahoo Canada Finance

Lifesci Capital Weighs in on Enliven Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ELVN) - Defense World

Q3 2024 EPS Estimates for Enliven Therapeutics, Inc. (NASDAQ:ELVN) Increased by Analyst - MarketBeat

Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet - Yahoo Finance

Enliven Therapeutics (NASDAQ:ELVN) Releases Quarterly Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat

Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Up to $21.52 - MarketBeat

Enliven Therapeutics begins patient dosing in oncology drug trial - BizWest

Enliven Therapeutics stock holds Buy rating from TD Cowen on strong trial prospects - Investing.com Canada

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024 - InvestorPlace

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update - BioSpace

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update - GlobeNewswire

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update - Yahoo Finance

Vanguard Group Inc. Sells 47,622 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat

Vanguard Group Inc. Sells 47,622 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Trading (ELVN) With Integrated Risk Controls - Stock Traders Daily

Reviewing RAPT Therapeutics (NASDAQ:RAPT) & Enliven Therapeutics (NASDAQ:ELVN) - Defense World

Enliven Therapeutics (NASDAQ:ELVN) Trading Down 11.4% Following Insider Selling - Defense World

Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 991 Shares - Defense World

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Insider Joseph P. Lyssikatos Sells 3,099 Shares of Stock - Defense World

Enliven Therapeutics CEO sells $62,555 in company stock - Investing.com India

Enliven Therapeutics executive sells shares worth over $85k - Investing.com India

Enliven Therapeutics executive sells shares worth over $85k By Investing.com - Investing.com UK

Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Benjamin Hohl Sells 991 Shares - MarketBeat

Enliven Therapeutics (NASDAQ:ELVN) Trading Down 11.4% - MarketBeat

Enliven Therapeutics executive sells shares worth over $85k - Investing.com

Enliven Therapeutics director sells over $64k in company stock - Investing.com

Enliven Therapeutics director sells over $64k in company stock By Investing.com - Investing.com Canada

Enliven Therapeutics CEO sells $62,555 in company stock By Investing.com - Investing.com Canada

Enliven Therapeutics executive sells shares worth over $85k By Investing.com - Investing.com Canada

Enliven Therapeutics CFO sells shares worth over $27,000 - Investing.com

Enliven Therapeutics CEO sells $62,555 in company stock - Investing.com

Benjamin Hohl Sells 5,250 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World

Janus Henderson Group PLC Grows Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - MarketBeat

ELVNに似た銘柄